The characterization of this cell line has further contributed to define the characteristics of the rare group of SRF-NCOA2 neoplasms and their rhabdomyoblastic nature, clearly demonstrated by MYOD1 and myogenin expression by tumor cells. The gene discussed is SRF; the disease is neoplasm.